597 related articles for article (PubMed ID: 34528075)
21. Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality.
Aleksova A; Fluca AL; Gagno G; Pierri A; Padoan L; Derin A; Moretti R; Noveska EA; Azzalini E; D'Errico S; Beltrami AP; Zumla A; Ippolito G; Sinagra G; Janjusevic M
Life Sci; 2022 Dec; 310():121018. PubMed ID: 36183780
[TBL] [Abstract][Full Text] [Related]
22. COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge?
Del Turco S; Vianello A; Ragusa R; Caselli C; Basta G
Thromb Res; 2020 Dec; 196():143-151. PubMed ID: 32871306
[TBL] [Abstract][Full Text] [Related]
23. Sex differences in the cardiac stress response following SARS-CoV-2 infection of ferrets.
Rouhana S; Jacyniak K; Francis ME; Falzarano D; Kelvin AA; Pyle WG
Am J Physiol Heart Circ Physiol; 2023 Nov; 325(5):H1153-H1167. PubMed ID: 37737732
[TBL] [Abstract][Full Text] [Related]
24. Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?
Chang X; Ismail NI; Rahman A; Xu D; Chan RWY; Ong SG; Ong SB
Antioxid Redox Signal; 2023 Mar; 38(7-9):599-618. PubMed ID: 36053670
[No Abstract] [Full Text] [Related]
25. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.
Albini A; Di Guardo G; Noonan DM; Lombardo M
Intern Emerg Med; 2020 Aug; 15(5):759-766. PubMed ID: 32430651
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular Outcomes in the Acute Phase of COVID-19.
Nakano H; Shiina K; Tomiyama H
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920790
[TBL] [Abstract][Full Text] [Related]
27. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.
Hendren NS; Drazner MH; Bozkurt B; Cooper LT
Circulation; 2020 Jun; 141(23):1903-1914. PubMed ID: 32297796
[TBL] [Abstract][Full Text] [Related]
28. Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications.
Iwasaki M; Saito J; Zhao H; Sakamoto A; Hirota K; Ma D
Inflammation; 2021 Feb; 44(1):13-34. PubMed ID: 33029758
[TBL] [Abstract][Full Text] [Related]
29. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms.
Silva Andrade B; Siqueira S; de Assis Soares WR; de Souza Rangel F; Santos NO; Dos Santos Freitas A; Ribeiro da Silveira P; Tiwari S; Alzahrani KJ; Góes-Neto A; Azevedo V; Ghosh P; Barh D
Viruses; 2021 Apr; 13(4):. PubMed ID: 33919537
[TBL] [Abstract][Full Text] [Related]
30. Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19.
Medzikovic L; Cunningham CM; Li M; Amjedi M; Hong J; Ruffenach G; Eghbali M
J Mol Cell Cardiol; 2020 Nov; 148():25-33. PubMed ID: 32835666
[TBL] [Abstract][Full Text] [Related]
31. Covid-19 and the cardiovascular system: a comprehensive review.
Azevedo RB; Botelho BG; Hollanda JVG; Ferreira LVL; Junqueira de Andrade LZ; Oei SSML; Mello TS; Muxfeldt ES
J Hum Hypertens; 2021 Jan; 35(1):4-11. PubMed ID: 32719447
[TBL] [Abstract][Full Text] [Related]
32. Overcoming Barriers: The Endothelium As a Linchpin of Coronavirus Disease 2019 Pathogenesis?
Gustafson D; Raju S; Wu R; Ching C; Veitch S; Rathnakumar K; Boudreau E; Howe KL; Fish JE
Arterioscler Thromb Vasc Biol; 2020 Aug; 40(8):1818-1829. PubMed ID: 32510978
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular Manifestations of COVID-19 Infection.
Magadum A; Kishore R
Cells; 2020 Nov; 9(11):. PubMed ID: 33228225
[TBL] [Abstract][Full Text] [Related]
34. The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19.
Shi X; Chen M; Zhang Y
Mol Biol Rep; 2021 Feb; 48(2):1763-1771. PubMed ID: 33483864
[TBL] [Abstract][Full Text] [Related]
35. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner.
Agrawal H; Das N; Nathani S; Saha S; Saini S; Kakar SS; Roy P
Stem Cell Rev Rep; 2021 Feb; 17(1):94-112. PubMed ID: 33029768
[TBL] [Abstract][Full Text] [Related]
36. Myocardial injury and COVID-19: Possible mechanisms.
Babapoor-Farrokhran S; Gill D; Walker J; Rasekhi RT; Bozorgnia B; Amanullah A
Life Sci; 2020 Jul; 253():117723. PubMed ID: 32360126
[TBL] [Abstract][Full Text] [Related]
37. Endothelial cells and SARS-CoV-2: An intimate relationship.
Barbosa LC; Gonçalves TL; de Araujo LP; Rosario LVO; Ferrer VP
Vascul Pharmacol; 2021 Apr; 137():106829. PubMed ID: 33422689
[TBL] [Abstract][Full Text] [Related]
38. The SARS-CoV-2/Receptor Axis in Heart and Blood Vessels: A Crisp Update on COVID-19 Disease with Cardiovascular Complications.
Veluswamy P; Wacker M; Stavridis D; Reichel T; Schmidt H; Scherner M; Wippermann J; Michels G
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372552
[TBL] [Abstract][Full Text] [Related]
39. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.
Obi AT; Barnes GD; Napolitano LM; Henke PK; Wakefield TW
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):23-35. PubMed ID: 32916371
[TBL] [Abstract][Full Text] [Related]
40. Persistent Brainstem Dysfunction in Long-COVID: A Hypothesis.
Yong SJ
ACS Chem Neurosci; 2021 Feb; 12(4):573-580. PubMed ID: 33538586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
